Rheumatology Advance Access originally published online on May 10, 2007
Rheumatology 2007 46(7):1200-1206; doi:10.1093/rheumatology/kem125
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Provisional guidelines for applying the Department of Health (England) 18-week-patient pathway to specialist rheumatology care
1Honorary Consultant Rheumatologist, King's Mill Hospital, Sherwood Forest Hospitals NHS Foundation Trust, Mansfield Road, Sutton-in-Ashfield, NG17 4JL/Associate Professor and Clinical Reader, University of Nottingham Clinical Sciences Building, City Hospital, Hucknall Road, Nottingham, NG5 1PB, 2Consultant Physician and Rheumatologist, Queen Elizabeth Hospital, Sheriff Hill, Gateshead, NE96SX, 3Chief Executive, National Rheumatoid Arthritis Society, Unit B4 Westacott Business Centre, Westacott Way, Littlewick Green, Maidenhead, SL6 6AR, 4Consultant in Pain Medicine, Southampton University Hospitals NHS Trust. Pain Clinic, D Level Outpatient Centre, Royal South Hants Hospital, Southampton and 5Rheumatology Specialist Nurse, King's Mill Hospital, Sherwood Forest Hospitals NHS Trust, Mansfield Road, Sutton-in-Ashfield, NG17 4JL, UK.
Correspondence to: Dr. D. A. Walsh, Academic Rheumatology, University of Nottingham Clinical Sciences Building, Nottingham City Hospital, Hucknall Road, Nottingham, NG5 1PB, UK. E-mail: David.Walsh{at}nottingham.ac.uk
 |
Abstract |
|---|
Objectives. The Government Department of Health (England) has set a target that by 2008 patients on pathways that do or may involve medical or surgical consultant-led care should wait no longer than 18 weeks from referral to start of definitive treatment. Department of Health guidance must be interpreted and applied to patients with rheumatological problems.
Methods. Provisional guidelines have been prepared in collaboration between the British Society for Rheumatology, British Pain Society, Department of Health (England) and other key stakeholders.
Results. Definitive rheumatological treatment comprises a package of care rather than a single action. The care package usually requires input from a multidisciplinary team using several modalities in parallel. Actions within the care package that must be taken before treatment can be said to have started, are definitive actions. Definitive actions should be based on evidence of cost-effectiveness, tailored to the individual patient and offered irrespective of local availability or accessibility. They should be agreed between partners in the patient's care. This requires face-to-face consultation between the patient and a health care professional with appropriate expertise and knowledge. All definitive actions specified at the outset of management within specialist care must be initiated or removed by agreement from the patient's care package before the clock can be stopped in the 18-week-patient pathway.
Conclusions. Service redesign may be necessary in order to achieve an 18-week-patient pathway for all patients. A consistent and appropriate definition of clock-stops should ensure that patients will benefit from excellent rheumatology specialist care without unnecessary delay.
KEY WORDS: Guidelines, Patient-pathway, Integrated care, Plans, Health service
Submitted 19 February 2007;
revised version accepted 2 April 2007.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. A. Isenberg 30 million, around 10 000 ... and 18 ... Figuring out the optimal treatment for musculoskeletal conditions in the National Health Service Rheumatology, August 1, 2007; 46(8): 1219 - 1220. [Full Text] [PDF]
|
|